Priority Date: 16.03.12 (US 201261611950P)

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

  • Application ID: EP15151655
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1140.9
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A01, C07, and C12 is specialized in the combination A01, C07, and C12. We found, that Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Weickmann & Weickmann PartmbB, Vereenigde Octrooibureaux NV (V.O.) and 32 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 16.03.2012 - Priority Date (US 201261611950P)
  • 17.06.2015 - Publication A1 (EP2883449)

IPC Classification